|
|
|
 |
CES Ultra maxmium benefit at an
affordable price,
easy to use, portable |
History of CES
CES began in the former Soviet Union during the 1950s, its primary focus
being the treatment of sleep disorders, hence its initial designation as
"electro-sleep." Treatment of insomnia was soon overshadowed, however, by
psychiatric application for depression and anxiety. Since then, it has
been referred to by many other names, the most popular being "transcranial
electrotherapy" (TCET) and "neuroelectric therapy" (NET).
East European nations soon picked up CES as a treatment modality, and its
use spread worldwide. By the late 1960s, animal studies of CES had begun
in the United States at the University of Tennessee and what is now the
University of Wisconsin Medical School. These were soon followed by human
clinical trials at the University of Texas Medical School in San Antonio
and the University of Wisconsin Medical School. More studies followed.
There currently exist more than 1,000 articles on CES therapy many of
which are listed in four reviews put out by the Foreign Service Bulletin
of the United States Library of Congress. This is in addition to the
wealth of physiological and bio-engineering data on electro-sleep and
electro-anesthesia, including 18 experimental animal studies. Human
research studies on CES currently number more than 100. Its efficacy has
been clinically confirmed through 28 established psychometric tests,
computerized EEGs and topographical brain-mapping. Meta-analyses yielding
positive results from the use of CES have been conducted at the University
of Tulsa and at the Harvard University School of Public Health. The most
extensive work on CES is presently being conducted at the Pavlov Institute
in St. Petersburg, Russia.
|
